Li Wenle, Wang Gui, Wu Rilige, Dong Shengtao, Wang Haosheng, Xu Chan, Wang Bing, Li Wanying, Hu Zhaohui, Chen Qi, Yin Chengliang
Department of Orthopedics, Xianyang Central Hospital, Xianyang, China.
Clinical Medical Research Center, Xianyang Central Hospital, Xianyang, China.
Front Oncol. 2022 Jul 21;12:880305. doi: 10.3389/fonc.2022.880305. eCollection 2022.
Chondrosarcoma is a malignant bone tumor with a low incidence rate. Accurate risk evaluation is crucial for chondrosarcoma treatment. Due to the limited reliability of existing predictive models, we intended to develop a credible predictor for clinical chondrosarcoma based on the Surveillance, Epidemiology, and End Results data and four Chinese medical institutes. Three algorithms (Best Subset Regression, Univariate and Cox regression, and Least Absolute Shrinkage and Selector Operator) were used for the joint training. A nomogram predictor including eight variables-age, sex, grade, T, N, M, surgery, and chemotherapy-is constructed. The predictor provides good performance in discrimination and calibration, with area under the curve ≥0.8 in the receiver operating characteristic curves of both internal and external validations. The predictor especially had very good clinical utility in terms of net benefit to patients at the 3- and 5-year points in both North America and China. A convenient web calculator based on the prediction model is available at https://drwenle029.shinyapps.io/CHSSapp, which is free and open to all clinicians.
软骨肉瘤是一种发病率较低的恶性骨肿瘤。准确的风险评估对软骨肉瘤的治疗至关重要。由于现有预测模型的可靠性有限,我们打算基于监测、流行病学和最终结果数据以及四个中国医学机构开发一种可靠的临床软骨肉瘤预测指标。使用三种算法(最佳子集回归、单变量和Cox回归以及最小绝对收缩和选择算子)进行联合训练。构建了一个包含八个变量——年龄、性别、分级、T、N、M、手术和化疗——的列线图预测指标。该预测指标在区分度和校准方面表现良好,内部和外部验证的受试者操作特征曲线下面积均≥0.8。该预测指标在北美和中国的3年和5年时间点对患者的净获益方面尤其具有很好的临床实用性。基于该预测模型的便捷网络计算器可在https://drwenle029.shinyapps.io/CHSSapp获取,该计算器免费且向所有临床医生开放。